next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |52 |review
I think its wise to make acknowledgements and disclose potential conflicts of interests at the outset in these discussions. My funding largely comes from public health sources, with a small amount from other sources, including consulting for the pharmaceutical industry regarding drugs designed to help people stop using tobacco products. I don’t accept any funding from the tobacco industry, and did not accept an honorarium or coverage of travel/hotel expenses to attend to this meeting.